Selected research
Industry Growth & Trends
Global Pathogen mNGS Detection Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pathogen mNGS Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pathogen mNGS Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pathogen mNGS Detection market include BGI Genomics, Guangzhou Kingmed Diagnostics Group, Guangzhou Weiyuan Gene Technology, Capitalbio, Beijing Golden Key Gene Technology, IngeniGen, Difei Medical Technology, WillingMed Technology and Hangzhou Matridx Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pathogen mNGS Detection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pathogen mNGS Detection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pathogen mNGS Detection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pathogen mNGS Detection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pathogen mNGS Detection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pathogen mNGS Detection Market by Company
BGI Genomics
Guangzhou Kingmed Diagnostics Group
Guangzhou Weiyuan Gene Technology
Capitalbio
Beijing Golden Key Gene Technology
IngeniGen
Difei Medical Technology
WillingMed Technology
Hangzhou Matridx Biotechnology
Yuguo Biotechnology(Beijing)
Pathogen mNGS Detection Segment by Type
Technology Platform
Testing Service
Pathogen mNGS Detection Segment by Application
Hospital
Testing Facility
Other
Pathogen mNGS Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathogen mNGS Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathogen mNGS Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathogen mNGS Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pathogen mNGS Detection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Technology Platform
- Testing Service
Applications
- Hospital
- Testing Facility
- Other
Companies covered
- BGI Genomics
- Guangzhou Kingmed Diagnostics Group
- Guangzhou Weiyuan Gene Technology
- Capitalbio
- Beijing Golden Key Gene Technology
- IngeniGen
- Difei Medical Technology
- WillingMed Technology
- Hangzhou Matridx Biotechnology
- Yuguo Biotechnology(Beijing)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pathogen mNGS Detection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pathogen mNGS Detection Market Size by Region (2021-2032)
- 1.4.1 Global Pathogen mNGS Detection Market Size by Region (2021-2026)
- 1.4.2 Global Pathogen mNGS Detection Market Size by Region (2027-2032)
- 1.5 Key Regions Pathogen mNGS Detection Market Size (2021-2032)
- 1.5.1 North America Pathogen mNGS Detection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pathogen mNGS Detection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pathogen mNGS Detection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pathogen mNGS Detection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pathogen mNGS Detection Market Size Growth Rate (2021-2032)
2 Pathogen mNGS Detection Market by Type
- 2.1 Type Introduction
- 2.1.1 Technology Platform
- 2.1.2 Testing Service
- 2.2 Global Pathogen mNGS Detection Market Size by Type
- 2.2.1 Global Pathogen mNGS Detection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pathogen mNGS Detection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pathogen mNGS Detection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pathogen mNGS Detection Market Size by Regions
- 2.3.1 North America Pathogen mNGS Detection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pathogen mNGS Detection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pathogen mNGS Detection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pathogen mNGS Detection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pathogen mNGS Detection Market Size Breakdown by Type (2021-2026)
3 Pathogen mNGS Detection Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Testing Facility
- 3.1.3 Other
- 3.2 Global Pathogen mNGS Detection Market Size by Application
- 3.2.1 Global Pathogen mNGS Detection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pathogen mNGS Detection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pathogen mNGS Detection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pathogen mNGS Detection Market Size by Regions
- 3.3.1 North America Pathogen mNGS Detection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pathogen mNGS Detection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pathogen mNGS Detection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pathogen mNGS Detection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pathogen mNGS Detection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pathogen mNGS Detection Industry Trends
- 4.2 Pathogen mNGS Detection Industry Drivers
- 4.3 Pathogen mNGS Detection Industry Opportunities and Challenges
- 4.4 Pathogen mNGS Detection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pathogen mNGS Detection Revenue (2021-2026)
- 5.2 Global Pathogen mNGS Detection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pathogen mNGS Detection Key Company Headquarters & Area Served
- 5.4 Global Pathogen mNGS Detection Company, Product Type & Application
- 5.5 Global Pathogen mNGS Detection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pathogen mNGS Detection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pathogen mNGS Detection Players Market Share by Revenue in 2025
- 5.6.3 2025 Pathogen mNGS Detection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 BGI Genomics
- 6.1.1 BGI Genomics Company Information
- 6.1.2 BGI Genomics Business Overview
- 6.1.3 BGI Genomics Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 BGI Genomics Pathogen mNGS Detection Product Portfolio
- 6.1.5 BGI Genomics Recent Developments
- 6.2 Guangzhou Kingmed Diagnostics Group
- 6.2.1 Guangzhou Kingmed Diagnostics Group Company Information
- 6.2.2 Guangzhou Kingmed Diagnostics Group Business Overview
- 6.2.3 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Product Portfolio
- 6.2.5 Guangzhou Kingmed Diagnostics Group Recent Developments
- 6.3 Guangzhou Weiyuan Gene Technology
- 6.3.1 Guangzhou Weiyuan Gene Technology Company Information
- 6.3.2 Guangzhou Weiyuan Gene Technology Business Overview
- 6.3.3 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Product Portfolio
- 6.3.5 Guangzhou Weiyuan Gene Technology Recent Developments
- 6.4 Capitalbio
- 6.4.1 Capitalbio Company Information
- 6.4.2 Capitalbio Business Overview
- 6.4.3 Capitalbio Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Capitalbio Pathogen mNGS Detection Product Portfolio
- 6.4.5 Capitalbio Recent Developments
- 6.5 Beijing Golden Key Gene Technology
- 6.5.1 Beijing Golden Key Gene Technology Company Information
- 6.5.2 Beijing Golden Key Gene Technology Business Overview
- 6.5.3 Beijing Golden Key Gene Technology Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Beijing Golden Key Gene Technology Pathogen mNGS Detection Product Portfolio
- 6.5.5 Beijing Golden Key Gene Technology Recent Developments
- 6.6 IngeniGen
- 6.6.1 IngeniGen Company Information
- 6.6.2 IngeniGen Business Overview
- 6.6.3 IngeniGen Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 IngeniGen Pathogen mNGS Detection Product Portfolio
- 6.6.5 IngeniGen Recent Developments
- 6.7 Difei Medical Technology
- 6.7.1 Difei Medical Technology Company Information
- 6.7.2 Difei Medical Technology Business Overview
- 6.7.3 Difei Medical Technology Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Difei Medical Technology Pathogen mNGS Detection Product Portfolio
- 6.7.5 Difei Medical Technology Recent Developments
- 6.8 WillingMed Technology
- 6.8.1 WillingMed Technology Company Information
- 6.8.2 WillingMed Technology Business Overview
- 6.8.3 WillingMed Technology Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 WillingMed Technology Pathogen mNGS Detection Product Portfolio
- 6.8.5 WillingMed Technology Recent Developments
- 6.9 Hangzhou Matridx Biotechnology
- 6.9.1 Hangzhou Matridx Biotechnology Company Information
- 6.9.2 Hangzhou Matridx Biotechnology Business Overview
- 6.9.3 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Product Portfolio
- 6.9.5 Hangzhou Matridx Biotechnology Recent Developments
- 6.10 Yuguo Biotechnology(Beijing)
- 6.10.1 Yuguo Biotechnology(Beijing) Company Information
- 6.10.2 Yuguo Biotechnology(Beijing) Business Overview
- 6.10.3 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Product Portfolio
- 6.10.5 Yuguo Biotechnology(Beijing) Recent Developments
7 North America
- 7.1 North America Pathogen mNGS Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pathogen mNGS Detection Market Size by Country (2021-2026)
- 7.3 North America Pathogen mNGS Detection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pathogen mNGS Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pathogen mNGS Detection Market Size by Country (2021-2026)
- 8.3 Europe Pathogen mNGS Detection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pathogen mNGS Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pathogen mNGS Detection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pathogen mNGS Detection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pathogen mNGS Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pathogen mNGS Detection Market Size by Country (2021-2026)
- 10.3 South America Pathogen mNGS Detection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pathogen mNGS Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pathogen mNGS Detection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pathogen mNGS Detection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst